LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Inspire Pharmaceuticals Inc.
Headquarters:
Raleigh, NC, United States of America
Website:
N/A
Year Founded:
1995
Status:
Acquired
BioCentury
|
Apr 13, 2015
Company News
Merck & Co. Inc, Akorn deal
Read More
BioCentury
|
Sep 8, 2014
Company News
InSite, Inspire deal
Read More
BioCentury
|
Nov 25, 2013
Company News
Akorn, Merck sales and marketing update
Read More
BioCentury
|
Nov 18, 2013
Company News
InSite, Merck, Novartis, Pfizer ophthalmic news
Read More
BioCentury
|
Oct 14, 2013
Company News
InSite Vision Inc, Merck, Novartis, Pfizer ophthalmic news
Read More
BioCentury
|
Jul 1, 2013
Company News
InSite, Merck deal
Read More
BioCentury
|
Jun 24, 2013
Company News
InSite, Merck, Mylan, Pfizer ophthalmic news
Read More
BioCentury
|
Mar 4, 2013
Company News
Kala Pharmaceuticals management update
Read More
BioCentury
|
Mar 1, 2013
Financial News
Kala raises $11.5 million in series A
Read More
BioCentury
|
Aug 6, 2012
Clinical News
DexaSite dexamethasone: Phase III delayed
Read More
Items per page:
10
1 - 10 of 248